Supporting early career researchers focused on lung cancer
Career Enhancement Program
The Career Enhancement Program is here to help new researchers who are passionate about lung cancer by giving them funding and support to explore fresh ideas in understanding and treating the disease, while also encouraging diversity in the field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10891405 on NIH RePORTER |
What this research studies
The Career Enhancement Program (CEP) aims to support early career researchers dedicated to lung cancer by providing funding for their innovative research ideas related to the biology, prevention, diagnosis, and treatment of the disease. This program is designed to help young investigators transition into independent researchers, with a strong emphasis on mentorship from experienced faculty. The initiative also prioritizes the recruitment of researchers from underrepresented backgrounds to foster diversity in lung cancer research. Participants will benefit from a structured mentoring plan and access to a network of accomplished mentors in the field.
Who could benefit from this research
Good fit: Ideal candidates for this research are early career researchers, particularly those within three years of their faculty appointment or post-doctoral fellows with guaranteed faculty positions.
Not a fit: Patients who are not early career researchers or do not have a focus on lung cancer may not benefit from this program.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in lung cancer treatment and prevention strategies.
How similar studies have performed: Similar programs have successfully enhanced the careers of early-stage researchers in various medical fields, indicating a positive precedent for this approach.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Costa, Daniel Botelho — Dana-Farber Cancer Inst
- Study coordinator: Costa, Daniel Botelho
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.